Gary Romano
Company: Alector Pharmaceuticals LLC
Job title: Chief Medical Officer
Seminars:
Clinical Development of AL002, a Monoclonal Antibody Activating TREM2 Signaling Against Alzheimer’s Disease 9:00 am
• Outlining rationale for TREM2 agonism for the treatment of Alzheimer’s Disease • Exploring target engagement and treatment effects on microglial function • Evaluating safety and efficacy assessmentsRead more
day: Day One